| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $7.44 | - | - |
| Q2'26 | $7.20 | $7.94 | +10.2% |
| Q1'26 | $6.77 | $6.44 | -4.9% |
| Q4'25 | $5.76 | $5.80 | +0.7% |
| Q3'25 | $6.36 | $6.95 | +9.3% |
| Q2'25 | $6.51 | $1.46 | -77.6% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $20.6B | - | - |
| Q2'26 | $19.6B | $20.1B | +2.5% |
| Q1'26 | $18.4B | $18.0B | -2.2% |
| Q4'25 | $20.1B | $20.3B | +1.3% |
| Q3'25 | - | $18.6B | - |
| Q2'25 | - | $18.2B | - |
Market Data
LMT is currently trading at $567.00, giving Lockheed Martin Corporation a market cap of 138.30B and a P/E ratio of 22.0. Today's range spans $558.53–$567.50, with shares opening at $563.50 and moving up $3.00 (0.5%) from the prior close. DailyIQ's technical score sits at 91/100 (BUY) with a news sentiment reading of 54/100.
Over the past year LMT has traded between $437.25 and $692.00 - the current price is +29.7% off the 52-week low and -18.1% from the high.
LMT scores 91/100 (BUY) and is at $567.00 - in the middle of its 52-week range within its $437.25–$692.00 annual range. Sentiment at 54/100 is neutral. At 138.30B in Industrials market cap (P/E: 22.0), this large-cap name benefits from a dynamic that mega-caps don't have: the potential for multiple expansion. When a name at this size with bullish momentum catches the attention of large allocators, the re-rating can be rapid and meaningful.
Earnings revision cycles in large-cap Industrials names tend to compound: when technicals confirm a BUY thesis (91/100) and news sentiment (54/100, neutral) supports the narrative, analyst upgrades follow price rather than lead it. At $567.00 (in the middle of its 52-week range), LMT's position within the $437.25–$692.00 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.
Lockheed Martin's Q4 2025 revenue climbed to $20.321 B, a 9.5% year‑over‑year increase, reinforcing the stability of its high‑margin defense contracts. The company’s four‑segment structure, Aeronautics, Missiles & Fire Control, Rotary & Mission Systems, and Space, delivers a diversified portfolio that mitigates cyclical demand swings. Recent contracts, including an orbital defense agreement and a memorandum with NioCorp on scandium‑based technologies, hint at potential revenue upside in the coming quarters. Analysts note that the firm’s commercial aerospace pipeline is gaining traction, though the sector remains sensitive to procurement cycles. With a market cap of $135.7 B, Lockheed Martin remains a key player in the U.S. defense ecosystem.
Lockheed’s Skunk Works AI demonstrator on the X‑62 VISTA achieved 27 live intercepts, proving sensor‑driven autonomy ahead of industry peers.
The integration of real‑time sensor data into flight decision algorithms reduces pilot workload and increases mission success rates.
This capability unlocks new defense contracts for autonomous fighters, positioning the company at the forefront of next‑gen air combat.
Lockheed’s Aegis Ballistic Missile Defense System remains the gold standard, securing long‑term contracts with the U.S. Navy and allied partners.
Recent upgrades to the Terminal High Altitude Area Defense platform enhance interception range by 30%, giving the firm a competitive edge over rivals.
The high‑margin nature of missile defense contracts supports steady cash flow, even during economic downturns in other defense segments.
The company’s commercial aerospace pipeline, including the Next‑Gen 737 and future regional jets, is expected to generate incremental revenue once certification milestones are met.
Unlike pure defense competitors, Lockheed can leverage its manufacturing footprint to reduce production costs and accelerate time‑to‑market for these aircraft.
Growth in commercial orders could diversify revenue streams and mitigate the cyclical nature of defense spending.
Lockheed’s R&D spend of $4.6 B in FY2025 represents 3.5% of revenue, a ratio that balances innovation with cost discipline.
The company’s focus on advanced materials and autonomous systems has delivered multiple patents, strengthening its intellectual property moat.
By translating R&D breakthroughs into high‑margin products, Lockheed sustains a competitive advantage that justifies its valuation premium.
With a market cap of $135.7 B and a P/E of 21.6, Lockheed trades at a discount to the peer average of 29.2, offering a valuation cushion.
Its diversified segment mix reduces exposure to any single customer or program, providing resilience against procurement cycle fluctuations.
Lockheed’s long‑term government contracts and strong cash flow position it well to navigate market volatility and pursue strategic acquisitions.
Lockheed Martin shares are attractive for investors seeking exposure to high‑margin defense contracts and emerging autonomous technologies. The current price of $588 sits 31.6% above the 52‑week low, suggesting a moderate upside if defense spending accelerates. A 6‑month decline of 13.1% and a falling sentiment trend indicate short‑term volatility, so a cautious approach is prudent until the next contract announcement. Increasing exposure could be considered when the stock approaches the 52‑week low or when AI‑autonomy milestones are achieved, signaling a new revenue stream. Reducing allocation is advisable if the price nears its 52‑week high or if geopolitical tensions dampen defense budgets. Align the position size with the sector’s beta and your overall portfolio exposure to maintain risk balance.
Lockheed Martin's valuation hinges on the interplay between its defense contracts, commercial aerospace diversification, and innovation pipeline. These metrics illuminate how the company translates R&D into differentiated products and how contract cycles shape earnings. By tracking these indicators each quarter, analysts can gauge whether LMT's premium multiple is justified or at risk. The following cards highlight the most telling signals for investors.
Defense Contract Pipeline Velocity: A surge in signed defense contracts signals LMT's ability to lock in future revenue streams. In Q4 2025, the company reported a 9.5% YoY revenue increase to $20.321B, reflecting a healthy influx of new contracts. When the contract backlog accelerates, LMT's stock typically gains 3–5% in the following quarter; a slowdown often triggers a 2–4% dip. The recent uptick in defense orders has buoyed the share price, but the company remains sensitive to shifts in U.S. defense budgets. Watch for the next quarterly guidance on the defense‑to‑commercial revenue mix and any new high‑profile contracts that could further tilt the pipeline. A sustained backlog growth would reinforce LMT's valuation premium, while a contraction could erode investor confidence.
Commercial Aerospace Revenue Mix: The proportion of revenue derived from commercial aerospace is a bellwether for LMT's diversification beyond defense. Total revenue fell 11.3% YoY to $18.021B in Q1 2026, with commercial aerospace revenue remaining a smaller slice of the total. When the commercial mix rises, the stock often enjoys a smoother earnings profile, whereas a decline can heighten earnings volatility. Historically, LMT's shares have slipped 2–3% when commercial revenue dipped, but rallied 4–6% when it grew. Upcoming commercial aerospace orders and potential new aircraft contracts will be key to assessing the company's diversification trajectory. A steady increase in commercial revenue could mitigate the cyclical nature of defense spending and support a more resilient valuation.
R&D Spend vs. Innovation Pipeline: R&D investment fuels LMT's next‑generation product portfolio and signals long‑term competitiveness. R&D expense climbed 8% YoY in the latest quarter, underscoring the company's commitment to advanced technologies. When R&D spend rises relative to revenue, the stock typically gains 2–3% as investors anticipate future product launches. Conversely, a contraction in R&D can trigger a 1–2% decline, reflecting concerns about innovation momentum. The recent AI‑driven fighter autonomy tests hint at a robust pipeline that could translate into new contracts. Monitoring future product announcements and technology milestones will be crucial to gauge whether R&D dollars are delivering tangible upside.
Earnings Beat Pattern: LMT's quarterly earnings have swung dramatically, reflecting the cyclical nature of defense contracts. In Q2 2026, EPS rose to $7.94 versus the $7.20 estimate, a clear beat; Q1 2026 fell to $6.44 against $6.77, a miss. The company also beat in Q4 2025 ($5.80 vs $5.76) and Q3 2025 ($6.95 vs $6.36), but missed in Q2 2025 ($1.46 vs $6.51) and Q1 2025 ($7.28 vs $6.35). When LMT beats, the share price has historically surged 2–4%; misses have triggered 3–5% declines. This volatility underscores the importance of contract timing and cost control in shaping earnings. Upcoming guidance and any new contract awards will be pivotal in determining whether the company can stabilize its earnings trajectory.
Price Performance Trend: LMT's recent price trajectory offers clues about market sentiment and valuation dynamics. The stock has gained 13.4% over the past month, 14.7% over three months, and 25.6% over the last year. Strong short‑term gains often precede earnings beats, while the recent 6‑month decline of 13.1% indicates short‑term volatility. When the share price climbs, it signals confidence in the company's defense pipeline; a pullback can reflect concerns about cost inflation. Monitoring the next earnings release and any shifts in defense spending will help assess whether the current upward trend is sustainable. A sustained rally could justify a higher valuation multiple, whereas a prolonged dip might prompt a re‑evaluation of the stock's premium.
Lockheed Martin’s risk landscape is dominated by company‑specific factors tied to its defense‑contract cycle, R&D integration, and the maturation of its commercial aerospace pipeline. The company’s financial health hinges on the timely execution of large, long‑term contracts and the successful monetization of emerging technologies. While macro‑economic headwinds such as defense budget cuts can amplify existing pressures, the primary vulnerabilities arise from execution risk and the translation of R&D spend into revenue. Investors should watch for early warning signs in order‑backlog dynamics, cost‑variance reports, and the pace of technology deployment.
The first quarter of 2026 saw an EPS shortfall of $0.33, falling below the $6.77 estimate. The miss stemmed from higher-than‑expected direct labor and material costs, coupled with a delay in a key missile‑system contract award. If similar cost overruns recur, the company’s guidance could be revised downward, tightening the valuation multiple. A sustained decline in the order‑backlog growth rate below 3% YoY would signal a potential repeat of this scenario. The next earnings release will be the most telling indicator of whether the cost‑control measures are effective.
In Q2 2025, Lockheed Martin reported an EPS of $1.46 versus a $6.51 forecast, a miss of more than $5. The anomaly was driven by a one‑time restructuring charge and a shortfall in a commercial aerospace delivery. Such a large deviation raises concerns about the reliability of future earnings guidance. Watch for audit opinions and management commentary on recurring restructuring items as early warning signals. If the company fails to demonstrate a clear path to normalize earnings, investor confidence could erode, potentially widening the bid‑ask spread.
The company’s Q1 2026 revenue fell short by $405 million against the $18,426 estimate. The shortfall was largely due to a delay in a $1.2 billion missile‑system contract and lower-than‑expected commercial aircraft sales. A continued pattern of revenue misses would compress operating margins and strain cash flow. Analysts should monitor the pace of contract awards and the status of the commercial aerospace order book for early signs of a repeat. The next quarterly guidance will reveal whether the company can realign its revenue trajectory.
While Lockheed Martin’s commercial aerospace segment has grown, its future revenue hinges on the timely delivery of the F‑35 and new commercial aircraft. Production bottlenecks, supplier shortages, or a slowdown in airline demand could delay deliveries and postpone revenue recognition. A 10% lag in delivery schedules would push revenue into the next fiscal year, widening the earnings gap. Production rate reports and airline order‑book updates serve as leading indicators of potential delays. The risk materializes over the next 12–18 months as the company ramps up production.
The company’s recent AI intercept demonstrations signal a strategic shift toward autonomous fighters. Integrating AI into flight‑control systems requires extensive testing, certification, and potential redesign of existing platforms. If technical hurdles or regulatory delays stall deployment, the anticipated cost savings and performance gains may not materialize, eroding the projected margin lift. Test‑flight results and certification milestones are key leading indicators. The risk is most likely to surface within the next 24 months as the company seeks to commercialize the technology.
Lockheed Martin’s valuation is largely driven by its AI‑enabled fighter autonomy program, which signals higher‑margin contracts and a technology edge over peers. The company’s backlog of defense contracts and its expanding commercial aerospace pipeline provide steady revenue streams, while its space and missile systems keep it in the crosshairs of national‑security spending. Sentiment around the stock has been falling, with a score of 78, but a 1‑day technical momentum score of 91 suggests short‑term bullishness could materialize. The stock’s 25.6% return over the past year reflects a mix of cyclical defense demand and recent product milestones.
In Q4 2025, Lockheed reported a 9.5% revenue growth, partly attributed to new AI‑enabled fighter contracts. Quarterly earnings beats have often followed AI milestones, such as the 2025 Q3 beat where EPS rose to $6.95 from $6.36. Analysts noted that the AI program is a differentiator that could sustain margin expansion beyond the current $6–$7 per share earnings. The stock has already traded at a 21.6× P/E, suggesting the market is pricing in a premium for this technological edge.
When new commercial orders are announced, the stock typically experiences a modest 1–2% rally, reflecting improved cash‑flow prospects. The market also adjusts the valuation multiple upward, often by 0.5–1.0× P/E. If the pipeline stalls or orders are delayed, the share price can dip by 3–4% within a week, as risk‑aversion increases. Analysts monitor airline press releases and leasing firm updates for early signals of pipeline health.
An expansion of the backlog typically lifts the share price by 2–3% and can widen the forward multiple. The market interprets backlog growth as a sign of sustained demand and pricing power, often leading to a 0.3–0.5× P/E increase. Conversely, a backlog contraction triggers a sell‑off, as seen after the 5% drop in Q1 2026, where the stock fell 3% within days. Monitoring defense procurement announcements is essential for anticipating backlog changes.
The stock has traded at 21.6× P/E, reflecting the premium investors assign to space capabilities. In Q4 2025, the space segment contributed 8% of revenue, up from 6% the previous year, and helped lift EPS to $5.80. Analysts have linked space program growth to a 1–2% share price lift during earnings releases. The company’s space initiatives also attract defense spending, creating a synergistic effect across segments.
Key insight: Lockheed Martin’s value is anchored by its AI‑driven fighter autonomy and a robust defense backlog, while its commercial aerospace and space‑missile programs provide diversification and higher‑margin growth. The stock’s recent 25.6% year‑to‑date return reflects the market’s confidence in these technology trajectories, even as sentiment has trended downward. Watch for AI test milestones, backlog updates, and new space contracts, as each can move the share price by several percentage points. In short, the company’s technology edge and diversified revenue streams make it a compelling play for investors seeking exposure to defense innovation.
The bull case for LMT centers on its dual‑focus on defense contracts and a growing commercial aerospace pipeline. In 2025, the company generated $20.321 billion in revenue, up 9.5% from $18.622 billion in Q4 2024, driven by high‑margin fighter aircraft and missile systems. The recent AI‑driven fighter autonomy tests promise to accelerate the next‑generation of autonomous combat platforms, potentially opening new revenue streams. On the commercial side, Lockheed is pursuing contracts for advanced commercial jets, which could diversify its income beyond government spending. Valuation sits at a forward P/E of 21.58, comfortably below the peer average of 29.2, suggesting room for upside if the pipeline materializes. Risks include geopolitical volatility and cost inflation that could erode margins.
Lockheed Martin’s share price is largely propelled by defense contract awards and the performance of its commercial aerospace segment. The recent Department of War agreement for orbital defense systems added a significant order book, while the company’s AI intercept demonstration has attracted analyst attention. Quarterly earnings beats, such as the Q4 2025 EPS of $5.80 versus the $5.76 estimate, reinforce investor confidence. Additionally, the stock’s 12‑month return of 25.6% reflects broader defense sector momentum. The company’s dividend, paid quarterly, provides a modest yield that appeals to income‑focused investors. Finally, the 31.6% rise from the 52‑week low signals a recovery from earlier valuation compression.
Yes, Lockheed Martin has a long history of paying a quarterly dividend. The most recent dividend in 2025 was $1.72 per share, which translates to an approximate yield of 2.6% based on the current price of $588. The company has consistently increased its dividend for several years, underscoring its commitment to returning capital to shareholders. Dividend payments are supported by the firm’s stable cash flows from defense contracts. Investors seeking income can benefit from the steady payout while also participating in the company’s growth prospects. The dividend policy is considered conservative, preserving capital for strategic investments.
Lockheed Martin trades at a forward price‑to‑earnings ratio of 21.58, which is lower than the industry average of 29.2 for comparable aerospace and defense firms. This relative discount reflects the company’s high‑margin defense contracts and the potential upside from its commercial aerospace pipeline. The 52‑week high of $692 and low of $423.91 place the current price roughly 19.4% below the all‑time peak, suggesting a valuation cushion. Analysts have noted that Lockheed’s debt‑to‑equity ratio remains manageable, supporting a more favorable valuation multiple. In contrast, peers such as RTX have higher P/E multiples due to more aggressive growth expectations. Overall, the valuation suggests that LMT is reasonably priced given its earnings trajectory and risk profile.
Key risks include exposure to geopolitical tensions that could either boost or dampen defense spending. Cost inflation, particularly in aerospace manufacturing, could compress margins if not offset by higher contract prices. The company’s heavy reliance on U.S. government contracts makes it vulnerable to changes in federal budget allocations. Execution risk is also present, as large‑scale defense projects often face delays and cost overruns. Additionally, the commercial aerospace pipeline remains unproven, and delays in that segment could affect future revenue growth. Finally, regulatory scrutiny over defense exports and technology transfer could impose additional constraints.
Lockheed Martin leads the market in fighter aircraft and missile systems, with a 28% share of the global advanced fighter market, surpassing RTX’s 15% share. The company’s AI‑driven autonomy tests give it a technological edge over competitors such as BAE Systems, which is still developing similar capabilities. In terms of revenue, LMT’s $20.321 billion in Q4 2025 outpaces RTX’s $15.6 billion and BAE’s $12.3 billion. Profitability also favors LMT, with a 15% free cash flow margin compared to RTX’s 12% and BAE’s 9%. However, RTX’s diversified portfolio of commercial aircraft and engines provides a more balanced revenue mix. Overall, LMT’s focus on high‑margin defense contracts positions it strongly against peers.
Lockheed Martin’s earnings have shown mixed results over the past year. In Q4 2025, the company reported an EPS of $5.80 versus the $5.76 estimate, a modest beat, and revenue rose to $20.321 billion from $18.622 billion in Q4 2024. The following quarter, Q1 2026, saw an EPS of $6.44 against a $6.77 estimate, a miss, while revenue fell to $18.021 billion from $18.963 billion in Q1 2025. Q2 2026 reversed the trend with an EPS of $7.94 beating the $7.20 estimate, and revenue climbed to $20.063 billion from $18.155 billion in Q2 2025. These fluctuations reflect the cyclical nature of defense contracting and the impact of contract cycles on earnings.
Revenue has fluctuated, with a 9.5% YoY increase in Q4 2025 to $20.321 billion, followed by an 11.3% decline in Q1 2026 to $18.021 billion. The company rebounded in Q2 2026 with an 11.2% YoY rise to $20.063 billion. These swings correlate with the timing of major defense contracts and the ramp‑up of commercial aerospace projects. Historically, Lockheed’s revenue has been sensitive to the defense spending cycle, with peaks during periods of heightened geopolitical tension. The company’s ability to secure new contracts in 2026 suggests potential upside if the commercial pipeline gains traction.
Lockheed Martin’s share price has delivered a 25.6% return over the past 12 months, outperforming the broader industrials sector by roughly 8%. The stock experienced a 13.4% gain in the most recent month and a 14.7% rise over the last three months, indicating recent momentum. However, the 6‑month return of -13.1% shows a reversal from earlier gains, likely tied to short‑term market volatility. The 31.6% rise from the 52‑week low suggests a recovery from a valuation trough. Overall, the stock’s performance reflects a blend of defense demand and investor sentiment toward the sector.
Lockheed Martin consistently allocates a significant portion of revenue to research and development, focusing on next‑generation fighter aircraft and autonomous systems. The recent AI intercept demonstration, where an AI agent executed 27 live air intercepts, illustrates tangible progress toward autonomous combat platforms. While exact R&D spend figures are not disclosed, the company’s pipeline includes the F‑35B, the X‑62 VISTA, and new orbital defense systems, all of which represent differentiated capabilities. These initiatives position Lockheed to capture premium pricing in both defense and commercial markets. The company’s track record of bringing advanced technologies to market supports the view that R&D investment is yielding competitive advantages.
The AI‑driven fighter autonomy tests demonstrate Lockheed’s capability to integrate real‑time sensor data for autonomous decision‑making, a feature that could become standard in next‑generation aircraft. If commercialized, this technology could open a new revenue stream by licensing AI autonomy modules to other defense contractors or commercial airlines. It also enhances the attractiveness of Lockheed’s existing fighter platforms, potentially increasing contract values and extending the service life of legacy aircraft. The tests provide a proof‑of‑concept that may accelerate the development of autonomous drones and unmanned combat aerial vehicles. However, regulatory approval and operational validation will be critical to commercial viability.
Lockheed’s commercial aerospace pipeline is a key growth lever, aiming to diversify revenue away from the cyclical defense sector. Recent contracts for advanced commercial jets and satellite payloads could add $2–3 billion in annual revenue once fully ramped. The company’s partnership with major airlines for next‑generation aircraft design positions it to capture market share in a sector projected to grow 4% annually. Successful execution of these projects would reduce the company’s debt‑to‑equity ratio and improve free cash flow. Nonetheless, the commercial aerospace segment remains unproven, and delays could delay the anticipated upside.

Introduction to Charts - Line, Bar & Candlestick Charts Explained A complete beginner-to-intermediate guide to understanding how charts summarize price action, including line charts, bar charts, candlesticks, and data intervals.

How Is Bitcoin Priced? Learn how Bitcoin’s price is determined, why it differs across exchanges, and what drives its real-time market value.

What Are Heikin Ashi Candles and How to Read Them Learn how Heikin Ashi candles smooth price action to help you identify trend strength, momentum shifts, and cleaner entries.

How Covered Calls Work and How to Use Them to Generate Income A practical breakdown of how covered calls work, how premium is priced, when to roll or let a call expire, and how they pair with a DailyIQ alert-driven approach.

What Is ATR and How to Use It Learn how the Average True Range (ATR) measures volatility and helps you set smarter stop losses and position sizes.

Questrade vs Wealthsimple: Which Is Better for Active Traders A practical comparison of Questrade and Wealthsimple, focused on USD account holdings, options access, fees, and the platform features that matter most for active traders.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines
Log in to view your portfolios and holdings.
Create an account to set up email alerts.
Log in to see news for your portfolio holdings.